POLISCOPE
Back to bills
Part ofHealthcare →

The civic record

Read. Follow. Verify.
SB 430KANSASSession 2025-2026State BillSigned into law
Enacted

Kansas authorizes licensed physical therapists to perform certain capillary blood tests with patient consent

Original title: AN ACT concerning crimes, punishment and criminal procedure; reconciling multiple amendments to certain statutes; adding mitragynine to schedule I of the uniform controlled substances act; amending K.S.A. 21-5801, as amended by section 2 of 2026 House Bill No. 2413, and 21-6614, as amended by section 2 of 2025 House Bill No. 2323, and K.S.A. 2025 Supp. 65-4105, as amended by section 2 of 2025 House Bill No. 2365, and repealing the existing sections; also repealing K.S.A. 21-5801, as amended by section 7 of 2025 House Bill No. 2347, and 21-6614, as amended by section 4 of 2025 House Bill No. 2393.

Last action · April 10, 2026: Conference committee report now available

Bill progressHistory & official text ↓
Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Does

Licensed physical therapists in Kansas are now permitted to perform specific CLIA-waived capillary blood tests, such as lactate and blood glucose assessments, to support rehabilitation and muscle metabolism tracking. The law requires therapists or their facilities to hold a CLIA certificate of waiver, obtain written patient consent detailing supply costs, and refrain from billing third-party payers or diagnosing external medical conditions.

Why it matters

Licensed physical therapists gain explicit statutory authority to conduct specific fingerstick blood tests during patient evaluations, while patients must sign a written cost disclosure and assume financial responsibility for test supplies.

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Licensed physical therapists

Licensed physical therapists gain statutory permission to perform specific CLIA-waived capillary blood tests under defined conditions and subject to certificate and consent requirements.

Directly affected

Patients receiving physical therapy services

Patients must provide written consent and financial acknowledgment before undergoing capillary testing and may be charged for the reasonable cost of testing supplies.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

Can physical therapists diagnose medical conditions using these blood tests?
No. The law explicitly states that point-of-care laboratory testing by physical therapists does not grant independent authority to diagnose medical conditions outside the scope of physical therapy practice.
Will insurance or third-party payers cover these tests?
No. Physical therapists are prohibited from billing third-party payers for point-of-care laboratory testing as stand-alone reimbursable services, though patients may be charged for the reasonable cost of testing supplies.
What type of blood tests are physical therapists allowed to perform?
They are limited to assays classified by the Centers for Medicare and Medicaid Services as , specifically including lactate and blood glucose tests used for muscle metabolism, exercise tolerance, or rehabilitation.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Follow the record

Votes, people, money & the original source

Where This Stands

Current status: Signed into law.

Procedural history

26 actions
  1. Apr 10, 2026House
    Conference committee report now available
  2. Apr 10, 2026HouseFloor
    Motion to suspend Joint Rule 4 (k) to allow consideration adopted
  3. Apr 10, 2026HouseFloor
    Conference Committee Report was adopted
  4. Apr 10, 2026SenateFloor
    Motion to suspend Joint Rule 4 (k) to allow consideration adopted
  5. Apr 10, 2026SenateFloor
    Conference Committee Report was adopted
  6. Apr 10, 2026Senate
    Enrolled and presented to Governor on Friday, April 17, 2026
Show 20 earlier actions
  1. Apr 10, 2026SenateEnrolled
    Approved by Governor on Monday, April 27, 2026
  2. Mar 23, 2026Senate
    Nonconcurred with amendments; Conference Committee requested; appointed , and
  3. Mar 23, 2026HouseFloor
    Motion to accede adopted; Representative Carpenter, Representative Bryce, Representative Ruiz, , appointed as conferees
  4. Mar 12, 2026HouseFloor
    Final Action - Passed as amended
  5. Mar 11, 2026House
    Committee of the Whole - Now working on
  6. Mar 11, 2026HouseFloor
    Committee of the Whole - Committee Report be adopted
  7. Mar 11, 2026HouseFloor
    Committee of the Whole - Be passed as amended
  8. Mar 9, 2026HouseFloor
    Committee Report recommending bill be passed as amended by
  9. Mar 4, 2026House
    Hearing: Wednesday, March 4, 2026, 1:30 PM — Room 112-N
  10. Feb 25, 2026HouseIntroduced
    Received and Introduced
  11. Feb 25, 2026HouseCommittee
    Referred to House Committee on Health and Human Services
  12. Feb 18, 2026Senate
    Committee of the Whole - Now working on
  13. Feb 18, 2026SenateFloor
    Committee of the Whole - Committee Report be adopted
  14. Feb 18, 2026SenateFloor
    Committee of the Whole - Be passed as amended
  15. Feb 18, 2026Senate
    fa_fabc_912
  16. Feb 18, 2026SenateFloor
    Emergency Final Action - Passed as amended
  17. Feb 12, 2026SenateFloor
    Committee Report recommending bill be passed as amended by
  18. Feb 11, 2026Senate
    Hearing: Wednesday, February 11, 2026, 8:30 AM — Room 142-S
  19. Feb 2, 2026SenateCommittee
    Referred to Senate Committee on Public Health and Welfare
  20. Jan 30, 2026SenateIntroduced
    Introduced

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Connected Entities

Centers for Medicare and Medicaid Services
OrganizationCenters for Medicare and Medicaid Services“Federal agency that classifies laboratory tests as CLIA-waived.”Map →

Sources

Open source document

www.kslegislature.gov

Analysis Score

0–100
  • Significance45
    How much this matters to a regular citizen
  • Controversy15
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz20
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record